Full video transcriptClick to expand
Auto-generated transcript of @michelehormonehealth's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.
- 0:00If you don't feel as great as you thought you would after starting testosterone therapy,
- 0:03this could be why. Sex hormone binding globulin or SHBG binds your hormones,
- 0:07especially testosterone, so they're not active. So then you can have a normal total testosterone
- 0:12level, but if your SHBG is high, you may not feel it. And then you would experience things like low
- 0:17libido, fatigue, brain fog, or poor response to testosterone therapy. This is why checking total
- 0:22testosterone alone misses the full picture. What matters is what's free, and SHBG controls that.
- 0:28What helps depends on why it's high, but big patterns to look at are things like enough carbs
- 0:33and protein, S-gen route because oral can raise SHBG, insulin patterns, thyroid function, and testosterone
- 0:39dosing or form. If your total testosterone labs look fine but you don't feel fine, SHBG is one of
- 0:44the first things to check.
SHBG and testosterone in women: what the science actually supports
Quick answer
SHBG is a glycoprotein produced primarily in the liver that binds testosterone and estradiol with high affinity, reducing their bioavailability. In women on testosterone therapy, elevated SHBG can result in normal or high total testosterone readings alongside low free testosterone, which may partly explain persistent symptoms. However, free testosterone measurement is methodologically inconsistent across clinical labs, and symptom attribution to SHBG alone requires ruling out thyroid dysfunction, metabolic factors, and other androgen pathway variables.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Access rules depend on the compound and patient situation
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 7 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For SHBG and testosterone in women: what the science actually supports, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Cardiovascular Safety of Testosterone-Replacement Therapy
TRAVERSE trial anchor for cardiovascular-safety discussions in appropriately diagnosed men.
PubMed
Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline
Guideline anchor for diagnosis, monitoring, contraindications, and appropriate TRT framing.
PubMed
The human peptide GHK-Cu in prevention of oxidative stress and degenerative conditions of aging
Anchor review for copper peptide gene-expression and tissue-repair claims.
PubMed
Effects of glycyl-histidyl-lysine-Cu on wound healing
Search-backed PubMed trail for wound-healing claims where specific topical versus injectable context matters.
PubMed
Provider decision path
Use local research to choose a safer review path
Direct answer
SHBG and testosterone in women: what the science actually supports is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.
Evidence check
Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.
Safety check
Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.
Next step
When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.
Claim path
Keep researching this testosterone and trt video claims cluster
Best for searchers turning TRT social claims into a safer lab-backed provider discussion.
Page-specific review note
What this exact clip is really saying
This FormBlends review is specific to "SHBG and testosterone in women: what the science actually supports" from Dr. Michele Oller, PharmD. We read the clip as a TRT social video fact-checks claim about Testosterone, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: SHBG is a glycoprotein produced primarily in the liver that binds testosterone and estradiol with high affinity, reducing their bioavailability.
The reason this review is not generic is the source wording and the canonical claim label "trt if your testosterone looks normal but you still feel off shb." In this clip, the useful excerpt is: "If you don't feel as great as you thought you would after starting testosterone therapy, this could be why." That wording changes the review because it points to Testosterone evidence, safety, and patient-fit context, not a one-size-fits-all protocol.
The source trail for this page is checked against Cardiovascular Safety of Testosterone-Replacement Therapy (2023), Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline (2010), and Functional testosterone deficiency in aging men: Clinical impact, diagnostic pathways, and treatment strategies (2026), plus the creator's own wording. Testosterone decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.
Claim verdict
The useful answer behind this video
This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.
Claim being checked
SHBG is a glycoprotein produced primarily in the liver that binds testosterone and estradiol with high affinity, reducing their bioavailability.
FormBlends verdict
Testosterone evidence, safety, and patient-fit context
Evidence strength
Source-backed review with clinical or regulatory citations.
Patient-safe next step
Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- SHBG is a glycoprotein produced primarily in the liver that binds testosterone and estradiol with high affinity, reducing their bioavailability. In women on testosterone therapy, elevated SHBG can result in normal or high total testosterone readings alongside low free testosterone, which may partly explain persistent symptoms. However, free testosterone measurement is methodologically inconsistent across clinical labs, and symptom attribution to SHBG alone requires ruling out thyroid dysfunction, metabolic factors, and other androgen pathway variables.
- SHBG binds testosterone with high affinity, and elevated levels can reduce free testosterone even when total testosterone appears normal on standard labs.
- Free testosterone measurement is not standardized across labs. Equilibrium dialysis is most accurate but rarely used in clinical practice, meaning a single free testosterone number should be interpreted cautiously.
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compound access, legal status, and product quality still need a separate safety check.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.
Start provider reviewWhat You'll Learn
- SHBG binds testosterone with high affinity, and elevated levels can reduce free testosterone even when total testosterone appears normal on standard labs.
- Free testosterone measurement is not standardized across labs. Equilibrium dialysis is most accurate but rarely used in clinical practice, meaning a single free testosterone number should be interpreted cautiously.
- Oral estrogen and oral testosterone raise SHBG through first-pass liver metabolism. Transdermal and injectable routes do not carry this effect, which is a real pharmacokinetic consideration in therapy planning.
- Longcope et al. (2000, AJCN) found dietary composition influences SHBG, but effect sizes are modest. Nutrition can be one factor, not a standalone fix.
- Symptoms like fatigue, brain fog, and low libido overlap with thyroid dysfunction, iron deficiency, sleep disorders, and depression. SHBG should be investigated as part of a broader panel, not treated as the default explanation.
- No consensus exists on what free testosterone level constitutes deficiency in women. Islam et al. (2021, JCEM) identified lack of standardized assays and normative data as a persistent barrier to diagnosis.
- If your provider is only running total testosterone, asking to add SHBG, free testosterone, thyroid panel, and ferritin is a clinically reasonable request based on current evidence.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.
What did @michelehormonehealth actually say?
The core claim here is straightforward: if your total testosterone looks normal but you still feel terrible, high SHBG could be binding up your testosterone and leaving you with very little free, active hormone. She lists fatigue, low libido, and brain fog as symptoms, and suggests looking at carbs, protein, delivery route, insulin patterns, thyroid, and dosing as potential levers.
She also makes a pointed clinical argument: "checking total testosterone alone misses the full picture." That's not fringe thinking. It's a real debate that's been simmering in endocrinology for over a decade. She's not selling a quick fix here. She's pointing at a mechanism and suggesting it warrants investigation. That's a reasonable starting point, even if some of the details deserve scrutiny.
Does the science back this up?
Mostly, yes. SHBG absolutely binds testosterone, and high SHBG does reduce free testosterone availability. This is not controversial. The question is whether free testosterone measurements actually predict symptoms better than total testosterone. The evidence is more complicated than the video suggests.
A 2019 analysis by Handelsman in the Journal of Clinical Endocrinology and Metabolism argued that calculated free testosterone has serious methodological limitations, including errors introduced by albumin assumptions and assay variability. The equilibrium dialysis method for measuring free testosterone is considered most accurate but is rarely done in clinical practice. Meanwhile, a 2020 study by Davis and colleagues in Menopause found that free androgen index and calculated free testosterone correlated modestly with sexual function outcomes in perimenopausal women, but the associations were not strong enough to make free testosterone a reliable standalone diagnostic tool.
So yes, SHBG matters. But "what matters is what's free" is a bit cleaner than the actual evidence warrants.
What did they get wrong (or right)?
She gets the mechanism right. High SHBG reduces bioavailable testosterone. That's solid biochemistry. She also gets credit for flagging oral delivery as a potential SHBG-raising route. Oral testosterone and oral estrogen are both known to increase hepatic SHBG production through first-pass liver metabolism. That's a real clinical consideration backed by pharmacokinetic data.
Where she oversimplifies: the claim that symptoms like brain fog and low libido are explained by high SHBG is presented as more direct than the evidence supports. These symptoms are nonspecific and overlap with thyroid dysfunction, depression, sleep disorders, and perimenopause itself. Attributing poor therapy response primarily to SHBG without ruling out other causes is a shortcut that could mislead viewers.
The nutrition advice, specifically "enough carbs and protein," is genuinely interesting. There is some evidence that low-carbohydrate diets raise SHBG, with a frequently cited study by Longcope and colleagues in the American Journal of Clinical Nutrition (2000) showing dietary fiber and fat intake influenced SHBG levels. But the effect sizes are modest, and framing macronutrient intake as a primary SHBG intervention oversells the data.
She also mentions insulin patterns and thyroid function as SHBG modulators. Both are legitimate. Insulin resistance suppresses SHBG, and hypothyroidism lowers it. Hyperthyroidism raises it. These are accurate associations, though they're stated without much nuance.
What should you actually know?
If you're on testosterone therapy and still feel off, SHBG is worth checking. But it's one variable in a panel that should also include free testosterone via equilibrium dialysis if possible, thyroid function, cortisol, iron studies, and a honest assessment of sleep quality and mental health.
The bigger issue the video doesn't address is that "optimal" free testosterone ranges for women are not well established. Reference ranges vary significantly by lab, and there's no agreed threshold at which free testosterone reliably improves symptoms. A 2021 review by Islam and colleagues in the Journal of Clinical Endocrinology and Metabolism noted that defining androgen deficiency in women remains hampered by lack of standardized assays and population-based normative data.
If your provider is only running total testosterone and calling it a day, this video gives you a reasonable prompt to ask for a more complete panel. That's genuinely useful. But don't walk away thinking high SHBG is definitively why you feel bad. It might be part of the story. It's rarely the whole one.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
Dr. Michele Oller, PharmD · TikTok creator
10.4K views on this video
If your testosterone looks normal but you still feel off — SHBG might be why. This is one of the most overlooked reasons women don’t feel better… even on therapy. Symptoms matter — but so does understanding what’s actually active. More detail + resources linked in bio. #highshbg #hormoneimbalance #lowtestosteronewomen #perimenopause #hormonehealth high shbg in women how to lower shbg what is shbg hormone high shbg symptoms female low free testosterone women why testosterone not working wome
Frequently asked questions
Quick answers based on this video and our medical team review.
What does the video say about shbg binds testosterone with high affinity,?
SHBG binds testosterone with high affinity, and elevated levels can reduce free testosterone even when total testosterone appears normal on standard labs.
What does the video say about free testosterone measurement?
Free testosterone measurement is not standardized across labs. Equilibrium dialysis is most accurate but rarely used in clinical practice, meaning a single free testosterone number should be interpreted cautiously.
What does the video say about oral estrogen?
Oral estrogen and oral testosterone raise SHBG through first-pass liver metabolism. Transdermal and injectable routes do not carry this effect, which is a real pharmacokinetic consideration in therapy planning.
What does the video say about longcope et al. (2000, ajcn) found dietary composition influences shbg,?
Longcope et al. (2000, AJCN) found dietary composition influences SHBG, but effect sizes are modest. Nutrition can be one factor, not a standalone fix.
What does the video say about symptoms like fatigue, brain fog,?
Symptoms like fatigue, brain fog, and low libido overlap with thyroid dysfunction, iron deficiency, sleep disorders, and depression. SHBG should be investigated as part of a broader panel, not treated as the default explanation.
What does the video say about no consensus exists on what free testosterone level constitutes deficiency?
No consensus exists on what free testosterone level constitutes deficiency in women. Islam et al. (2021, JCEM) identified lack of standardized assays and normative data as a persistent barrier to diagnosis.
Sources & references
Citations extracted from our medical team's review. Click any citation to search PubMed.
Read More on This Topic
Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.
Not medical advice. This video was made by Dr. Michele Oller, PharmD, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.